References
- Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994;47:278–282.
- Dummer R, Potoczna N, Huffner AC, et al. A primary cutaneous non-T, non-B CD4 + CD56+ lymphoma. Arch Dermatol 1996;132:550–553.
- Di Giuseppe JA, Louie DC, Williams JE. Blastic natural killer leukaemia/lymphoma: A clinicopathologic study. Am J Surg Pathol 1997;21:1223–1230.
- Savoia P, Fierro MT, Novelli M, et al. CD-56 positive cutaneous lymphoma: A poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997; 137:966–971.
- Petrella T, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: A distinct haematological entity? Am J Surg Pathol 1999;23:137–146.
- Chan JKC, Jaffe E, Ralfkiaer E. Blastic NK-cell lymphoma, in World Health Organization classification of tumours: Patho-logy and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p 214–215.
- Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4+ CD56+ malignancies. Blood 2002;99: 1556–1563.
- Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97:3210–3217.
- Suzuki R, Nakamura S, Suzumiya J, et al. Blastic natural killer cell lymphoma/leukaemia (CD56-positive blastic tumor). Cancer 2005;104:1022–1031.
- Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+ CD56+ hematodermic neo-plasms). Am J Clin Pathol 2005;123:662–675.
- Ng AP, Lade S, et al. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma). Haematologica 2006;91:143–144 (letter).